Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile shares traded near $195 midday Monday, down slightly, as SoftBank sold $4.8 billion of its stake to help fund a $22.5 billion OpenAI commitment, Reuters reported. The company recently authorized a $14.6 billion shareholder return program and will pay a $1.02 quarterly dividend in March. Bernstein reiterated a Neutral rating with a $265 target. Analyst consensus remains “Buy” with an average target of $262.
22 December 2025
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery shares rose Monday, closing near $28.70, after Paramount Skydance amended its $30-per-share hostile offer by adding a $40.4 billion personal guarantee from Larry Ellison. Netflix also revealed new financing moves for its agreed deal with WBD assets. Paramount extended its tender offer to January 21, 2026. Only 397,252 shares had been tendered as of December 19.
Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon shares traded near $211 on Dec. 22, up 0.8%, as investors reacted to CEO Calvin McDonald’s planned departure and news of Elliott Management’s $1 billion-plus stake. Meghan Frank and André Maestrini will serve as interim co-CEOs starting Jan. 31. The company also announced expansion into six new international markets in 2026.
Wells Fargo Stock (WFC) Today: Options-Clearing Push, Fresh Deal Headlines, and What Forecasts Say for 2026

Wells Fargo Stock (WFC) Today: Options-Clearing Push, Fresh Deal Headlines, and What Forecasts Say for 2026

Dec. 22, 2025 — Wells Fargo & Company (NYSE: WFC) is in focus heading into the final stretch of the year as investors weigh a new strategic move in markets, fresh deal-related headlines tied to big-ticket financing, and a still-shifting U.S. interest-rate backdrop. Shares of Wells Fargo stock traded higher on Monday, hovering around $94 and up about 1% on the day at the time of reporting. With the stock near recent highs, attention is turning from the “cleanup and recovery” narrative toward what Wells can build now that its balance sheet is no longer constrained by the long-running regulatory
22 December 2025
Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks shares rose 1.5% to $189.65 on Dec. 22 after news of an expanded Google Cloud partnership, reportedly worth nearly $10 billion over several years. The deal includes integrating Palo Alto’s AI security tools with Google Cloud services and expanding firewall and SASE deployments. Analysts highlighted the partnership’s potential to drive recurring revenue but noted execution risks remain.
ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow shares traded at $156.25 as of 17:00 UTC, up 0.6% after a 5-for-1 stock split took effect Dec. 18. The company completed its acquisition of Moveworks and is in reported talks to buy cybersecurity firm Armis for up to $7 billion. Shares fell over 11% on Dec. 15 after the Armis news surfaced. Analyst concerns focus on deal size and growth strategy.
22 December 2025
Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

NEW YORK — December 22, 2025 — Goldman Sachs Group, Inc. (The) (NYSE: GS) is ending 2025 with its stock hovering near the top of its yearly range, fueled by renewed confidence in global dealmaking, steady client activity across market cycles, and a growing narrative that productivity gains from AI could lift profitability further in 2026. By midday trading on Monday, GS shares were around $903, up roughly 1% on the session, after moving between the high-$890s and low-$900s. Barchart.com With the bank’s next earnings release scheduled for Thursday, January 15, 2026, investors now face a familiar late-year tension: Goldman’s
22 December 2025
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard shares rose 0.8% to $576.90 on Dec. 22 after Fiserv expanded its partnership with the company to scale AI-driven “agentic commerce” for merchants. Mastercard also announced a new B2B payments launch with First Abu Dhabi Bank and a 14% dividend increase with a $14 billion buyback. Fee-related litigation and regulation remain in focus.
22 December 2025
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie shares traded at $227.73 midday Monday, near recent highs, as the company remains one of three major drugmakers not signed onto the White House’s new “most-favored-nation” drug-pricing agreements announced December 19. Investors are watching for AbbVie’s next move on the policy front, while its core immunology drugs and dividend growth continue to anchor fundamentals.
Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Dec. 22, 2025 — Citigroup Inc. (NYSE: C) is ending the year with momentum. In Monday trading, Citigroup stock pushed to a new 52‑week high and traded around $118, extending a powerful 2025 rally that has been driven by a mix of turnaround execution, capital return, and—most recently—regulatory overhang starting to lift. Investing.com+1 For investors trying to separate signal from noise, today’s Citi story is less about a single headline and more about a cluster of developments that collectively support the “simplification + risk-control repair + returns” thesis CEO Jane Fraser has been selling for years—now with outside validation from
22 December 2025
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen shares rose to around $331 on December 22, 2025, after the White House announced drug-pricing deals with major drugmakers, including Amgen. The company will offer Aimovig and Amjevita at $299 per month through direct-to-patient sales. Analysts said the agreements may ease tariff and political risks but are unlikely to significantly affect pharma profits in the near term.
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot shares traded around $347 Monday afternoon, up 0.7% for the day, as investors weighed new analyst commentary and 2026 outlooks. Wolfe Research nudged its price target to $415 and reiterated an Outperform rating. The stock remains down about 10% to 11% year-to-date, lagging the broader market. Trading volume and price range stayed steady, with no major corporate news.
22 December 2025
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals joined the Nasdaq-100 Index on Dec. 22, 2025, as the annual reconstitution took effect before the market opened. Shares traded near $405.60, up 1.3% from the prior close. The company recently announced a $250 million U.S. manufacturing expansion and reported strong adoption of its AMVUTTRA therapy for transthyretin amyloidosis.
Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson shares traded at $206.63 Monday after the European Commission approved TREMFYA for pediatric psoriasis, marking its first IL-23 inhibitor indication in children. The company also secured recent FDA approvals for RYBREVANT FASPRO in lung cancer and TRUFILL n-BCA for chronic subdural hematoma. Ongoing talc litigation continues to affect investor sentiment.
22 December 2025
Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems joined the Nasdaq-100 Index before the market opened Monday, Dec. 22, 2025. Shares traded near $958.73, up 2.3% on the day, with a session range of $949.33 to $970.00. Analysts maintain a “Buy” consensus, with a 12-month average target of $1,196. The company declared a $1.56 quarterly dividend, payable Jan. 15, 2026.
Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil (XOM) Stock News Today: Fresh Catalysts, Analyst Forecasts, and What to Watch on December 22, 2025

Exxon Mobil shares traded near $118 on Dec. 22, 2025, as investors assessed steady oil prices and the company’s updated 2030 growth plan. Exxon projects $25 billion in earnings growth and $35 billion in cash flow by 2030, with no increase in capital spending. A CFO transition is set for February 2026. Guyana and the Permian Basin remain key project areas.
22 December 2025
Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce (CRM) Stock News Today: Latest Headlines, Analyst Forecasts, and Agentforce AI Outlook (December 22, 2025)

Salesforce shares traded near $263 on December 22, 2025, valuing the company in the mid-$200 billion range. The stock is up 14.4% over the past four weeks amid upward earnings revisions, with fiscal 2026 EPS consensus at $11.67. Q3 results showed $10.3 billion in revenue and a 35.5% non-GAAP operating margin. Investors remain focused on AI monetization and institutional positioning.
1 432 433 434 435 436 613

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop